-
Amgen delivers earnings beat in Q3
07 Nov 2025 01:54 GMT
-
Stock Of The Day: Will Amgen Reverse Again?
06 Nov 2025 15:57 GMT
Amgen Inc. (NASDAQ:AMGN) is lower on Thursday. Yesterday, … , this is what happened with Amgen the last four times it … is an important level for Amgen.
When stocks reach important levels … days will be important for Amgen. Traders are watching it closely …
-
Amgen Inc. (NASDAQ:AMGN) Q3 2025 Earnings Call Transcript
06 Nov 2025 13:27 GMT
Amgen Inc. (NASDAQ:AMGN) Q3 2025 Earnings Call Transcript November 4, 2025
Amgen … A Session
Follow Amgen Inc (NASDAQ:AMGN) Follow Amgen Inc (NASDAQ:AMGN) Receive real … now disconnect.
Follow Amgen Inc (NASDAQ:AMGN) Follow Amgen Inc (NASDAQ:AMGN) Receive real …
-
Why Amgen Stock Was Crushing It on Wednesday
06 Nov 2025 06:24 GMT
… the healthcare field Wednesday was Amgen (AMGN +7.81%). The biotech … analyst estimates. Pundits tracking Amgen stock believed the company would … profit of $5.04.
Amgen attributed the better-than-expected … positions in and recommends Amgen. The Motley Fool has …
-
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Amgen, Cloudflare, Shopify, Super Micro Computer, Wingstop and More
06 Nov 2025 04:28 GMT
… objective for the shares.
Amgen Inc. (NASDAQ: AMGN) Goldman Sachs reiterated a …
-
Lilly partners with AI biologics company; Amgen ends gastric cancer study
05 Nov 2025 20:40 GMT
Plus, news about Rigel Pharmaceuticals, Ultragenyx, Neurocrine Biosciences, TransThera, MoonLake Immunotherapeutics, Kelonia Therapeutics, Johnson & Johnson and Harmony Biosciences:
🖊️ Eli Lilly signs deal …
-
Amid Obesity Bidding War, Amgen Believes It Can Stand Out in Crowded Space
05 Nov 2025 16:28 GMT
… antibody conjugate that, according to Amgen, can lead to stronger … their portfolios.”
Aside from MariTide, Amgen’s obesity push also includes … .
In the third quarter, Amgen’s revenue increased 12% year … .
For the entire year, Amgen expects its revenues to land …
-
Analyst recommendations: Nvidia, Tesla, IBM, AMD, Amgen…
05 Nov 2025 16:10 GMT
Déjà Vu, With Better Balance Sheets
For months, Wall Street has been running on an adrenaline rush. Now, the comedown has begun. After racing to record highs in October, U.S. markets have been jolted by a sudden case of vertigo. On Tuesday, the Nasdaq slid …
-
With sales booming, front-runner Amgen says US biosimilar market is already working
05 Nov 2025 14:12 GMT
… its biosimilars business thriving, Amgen is in a unique position … easing biosim regulatory standards, Amgen execs shared a word of … U.S. regulators have. Amgen believes, however, that relaxing … year. With the result, Amgen increased its 2025 revenue projection …
-
After Colorado put a price cap on its drug, Amgen sued the state board that did it. Again.
05 Nov 2025 13:29 GMT
… through stronger government regulation.
Amgen said the price cap, … the company financial damage.
“Amgen will suffer substantial, irreparable … King & Spalding.
Amgen reported making more than $ … standards,” making it arbitrary.
Amgen did not refile a claim …
About
© 1995-2025